DK1303635T3 - Fremgangsmåde til selektiv overlevelse eller selektiv vækst af en målcelle ved anvendelse af et konjugat til terapi og/eller diagnostik - Google Patents
Fremgangsmåde til selektiv overlevelse eller selektiv vækst af en målcelle ved anvendelse af et konjugat til terapi og/eller diagnostikInfo
- Publication number
- DK1303635T3 DK1303635T3 DK01960279T DK01960279T DK1303635T3 DK 1303635 T3 DK1303635 T3 DK 1303635T3 DK 01960279 T DK01960279 T DK 01960279T DK 01960279 T DK01960279 T DK 01960279T DK 1303635 T3 DK1303635 T3 DK 1303635T3
- Authority
- DK
- Denmark
- Prior art keywords
- target cell
- conjugate
- selective
- present
- diagnosis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 230000012010 growth Effects 0.000 title abstract 2
- 230000004083 survival effect Effects 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000010261 cell growth Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00870139 | 2000-06-21 | ||
| PCT/EP2001/006439 WO2001097854A2 (en) | 2000-06-21 | 2001-06-07 | Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1303635T3 true DK1303635T3 (da) | 2007-06-04 |
Family
ID=8175770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01960279T DK1303635T3 (da) | 2000-06-21 | 2001-06-07 | Fremgangsmåde til selektiv overlevelse eller selektiv vækst af en målcelle ved anvendelse af et konjugat til terapi og/eller diagnostik |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6969593B2 (da) |
| EP (1) | EP1303635B1 (da) |
| AT (1) | ATE354669T1 (da) |
| AU (1) | AU2001281814A1 (da) |
| DE (1) | DE60126776T2 (da) |
| DK (1) | DK1303635T3 (da) |
| ES (1) | ES2282281T3 (da) |
| WO (1) | WO2001097854A2 (da) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034634A1 (en) | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Single chain fv constructs of anti-ganglioside gd2 antibodies |
| JP2002511857A (ja) * | 1997-06-11 | 2002-04-16 | ザ スクール オブ ファーマシー ユニヴァーシティ オブ ロンドン | 抗体−酵素複合体をプロドラッグと組合せて含む薬学的組成物 |
-
2001
- 2001-06-07 DK DK01960279T patent/DK1303635T3/da active
- 2001-06-07 ES ES01960279T patent/ES2282281T3/es not_active Expired - Lifetime
- 2001-06-07 AT AT01960279T patent/ATE354669T1/de not_active IP Right Cessation
- 2001-06-07 US US10/311,786 patent/US6969593B2/en not_active Expired - Fee Related
- 2001-06-07 DE DE60126776T patent/DE60126776T2/de not_active Expired - Fee Related
- 2001-06-07 EP EP01960279A patent/EP1303635B1/en not_active Expired - Lifetime
- 2001-06-07 WO PCT/EP2001/006439 patent/WO2001097854A2/en active IP Right Grant
- 2001-06-07 AU AU2001281814A patent/AU2001281814A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE354669T1 (de) | 2007-03-15 |
| DE60126776D1 (de) | 2007-04-05 |
| ES2282281T3 (es) | 2007-10-16 |
| US20030099658A1 (en) | 2003-05-29 |
| EP1303635A2 (en) | 2003-04-23 |
| WO2001097854A2 (en) | 2001-12-27 |
| EP1303635B1 (en) | 2007-02-21 |
| DE60126776T2 (de) | 2007-10-31 |
| AU2001281814A1 (en) | 2002-01-02 |
| WO2001097854A3 (en) | 2002-04-11 |
| US6969593B2 (en) | 2005-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1526172T3 (da) | Fremgangsmåde til replikation af influenzavira i cellekultur og ved fremgangsmåden opnåelige influenzavira | |
| ATE466932T1 (de) | Vermehrung von viren in zellkultur | |
| DE69326685D1 (de) | Amplifikation von test reporters durch nukleinsäure replikation | |
| WO2006026738A3 (en) | Methods and compositions for rna amplification and detection using an rna-dependent rna-polymerase | |
| EA200400329A1 (ru) | Способы амплификации нуклеиновых кислот | |
| ES2163865T3 (es) | Aislamiento en fase solida de acidos nucleicos. | |
| DK0389063T3 (da) | Fremgangsmåde til isolering af nukleinsyre | |
| ATE260910T1 (de) | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) | |
| DE69630455D1 (de) | PRODUKTION VON BETA -GLUKAN-MANNAN PRÄPARATIONEN MITTELS AUTOLYSE VON ZELLEN UNTER BESTIMMTEN pH-, TEMPERATUR- UND ZEIT BEDINGUNGEN | |
| DK1724354T3 (da) | Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi | |
| WO2002084250A3 (en) | Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples | |
| NO20053179L (no) | Aldonsyreestere, fremgangsmater for fremstilling derav og fremgangsmater for fremstilling av farmasoytisk aktive ingredienser som er bundet til polysakkarider eller polysakkarid-derivater pa frie aminogrupper. | |
| WO2001083751A3 (en) | Methods for binding an exogenous molecule to cellular chromatin | |
| Skoreński et al. | Phosphonate inhibitors of West Nile virus NS2B/NS3 protease | |
| ATE322550T1 (de) | Verfahren zur bestimmung des vorhandenseins von bakterien, die gegen zell-lysierende antibiotika resistent sind | |
| AR039186A1 (es) | Celulas madre indiferenciadas programables de origen monocitaro, su obtencion y uso | |
| WO2005033330A3 (en) | Fluorescent probes for use in protein kinase inhibitor binding assay | |
| DE60132443D1 (de) | In lebenden zielzellen | |
| DK1851325T3 (da) | Fremgangsmåde til påvisning af levedygtige celler i en prøve ved anvendelse af en virus | |
| DK1303635T3 (da) | Fremgangsmåde til selektiv overlevelse eller selektiv vækst af en målcelle ved anvendelse af et konjugat til terapi og/eller diagnostik | |
| WO2005056763A3 (en) | Process and formulation to improve viability of stored cells and tissue | |
| DE59907570D1 (de) | Nachweis von zellen mittels spezifischer zellwand-bindender domänen (cbd) von zellwand-bindenden proteinen | |
| DE60038029D1 (de) | Methoden und reagenzien zur in situ amplifizierung | |
| EP1445327A4 (en) | SCREENING METHOD FOR A MEDICAMENT ACTIVE ON THE CELL WALL | |
| WO2006023211A3 (en) | Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof |